HC Wainwright Forecasts Aemetis' Q3 Earnings (NASDAQ:AMTX)

Key Points

• HC Wainwright raised its Q3 2026 EPS forecast for Aemetis to a loss of $0.19 per share from a previous estimate of $0.33, while projecting a path to profitability beginning in 2028.
• Aemetis reported a Q2 loss of $0.13 per share, beating the $0.29 consensus estimate, though revenue of $62.7 million fell short of the $67.69 million forecast.
• Analyst sentiment remains mixed, with Aemetis holding a consensus “Hold” rating and an average price target of $11.88; the stock recently traded at $1.86 and has a 52-week range of $1.30 to $3.80.

Aemetis, Inc (NASDAQ:AMTX - Free Report) - Stock analysts at HC Wainwright boosted their Q3 2026 earnings per share estimates for shares of Aemetis in a research note issued to investors on Tuesday, August 18th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings per share of ($0.19) for the quarter, up from their prior forecast of ($0.33). The consensus estimate for Aemetis' current full-year earnings is ($1.12) per share. HC Wainwright also issued estimates for Aemetis' Q4 2026 earnings at ($0.24) EPS, FY2026 earnings at ($0.88) EPS, FY2027 earnings at ($0.41) EPS, FY2028 earnings at $0.38 EPS, FY2029 earnings at $1.84 EPS and FY2030 earnings at $3.10 EPS.

Several other equities research analysts have also recently weighed in on the stock. Ascendiant Capital Markets upped their price objective on shares of Aemetis from $21.00 to $22.00 and gave the stock a "buy" rating in a research report on Friday, May 22nd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Aemetis in a report on Friday, July 17th. Finally, Wall Street Zen lowered shares of Aemetis from a "hold" rating to a "sell" rating in a research report on Saturday, June 6th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Aemetis currently has a consensus rating of "Hold" and an average target price of $11.88.

Aemetis Stock Performance

Shares of NASDAQ AMTX opened at $1.86 on Thursday. The stock has a market capitalization of $134.24 million, a P/E ratio of -2.04 and a beta of 1.48. The stock's fifty day moving average is $1.70 and its 200 day moving average is $2.07. Aemetis has a 52 week low of $1.30 and a 52 week high of $3.80.

Aemetis (NASDAQ:AMTX - Get Free Report) last released its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.16. The company had revenue of $62.70 million for the quarter, compared to the consensus estimate of $67.69 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp acquired a new stake in shares of Aemetis during the second quarter worth $283,000. Bank of America Corp DE grew its holdings in Aemetis by 148.3% during the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company's stock worth $324,000 after acquiring an additional 60,611 shares during the period. Royal Bank of Canada raised its position in shares of Aemetis by 10,632.5% in the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company's stock worth $28,000 after acquiring an additional 8,825 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Aemetis in the 1st quarter worth about $272,000. Finally, Sanctuary Advisors LLC acquired a new position in shares of Aemetis in the 1st quarter valued at about $33,000. 27.02% of the stock is owned by institutional investors and hedge funds.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source